A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

Researchers perform a head-to-head test on different disinfection methods using ultraviolet light to reveal the optimal protocol for deactivating coronaviruses.

Researchers develop a protocol to boost the effectiveness of and reduce the risk of potential side effects for T cell cancer therapies.

Researchers use single-cell sequencing for a new look at how stem cell-derived retinal cells fare after transplants for degenerative eye disorders.

New associations between COVID-19 and immune responses in cancer patients reveal potential inroads to fighting tumours.

Scientists discover genes encoding colours, scents and bioactive compounds in the genome of Papilionanthe Miss Joaquim, Singapore’s National Flower.

As Sir David and Birgit Lane leave Singapore, A*STAR Research commemorates the legacy that the couple continues to build for their students, colleagues and the nation’s wider research ecosystem.

Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.

Leveraging on its public sector and industry collaborations, A*STAR and the Experimental Drug Development Centre hold the keys to effective drug discovery and development.

By analysing heart cells, a new machine learning algorithm could help predict arrhythmia risk before symptoms appear.

In 2023, the National Research Foundation Singapore selected 10 A*STAR researchers to be a part of its competitive Investigatorship and Fellowship grant programmes.

Scalable and cost-effective methods for growing fat cells pose a commercialisation barrier for cultivated meat products.

After three decades as one of Singapore’s biomedical research pioneers, PSTA 2022 medallist Wanjin Hong reflects on his seminal work in the molecular biology of cancers, as well as the country’s evolving research landscape.